The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to ...

The man's family later sued OptumRx and Walgreens, claiming they didn't offer alternatives after his regular inhaler's price increased dramatically.

Hemsley projected 2026 adjusted EPS of greater than $17.75, targeting at least 8.6% growth, and outlined double-digit improvements at UnitedHealthcare alongside single-digit gains at Optum segments.

UnitedHealth Group Incorporated (NYSE:UNH) Q4 2025 Earnings Call Transcript January 27, 2026 UnitedHealth Group Incorporated ...

Sen. Travis Fitzwater, R-Holts Summit, continues to seek regulations on how pharmacy benefit managers (PBMs) can operate in Missouri.

UnitedHealth Group reported Q4 2025 EPS of $2.11 on revenue of $113.2 billion, missing estimates, while outlining a cautious ...

The industry that negotiates drug prices for employers has worked to stay ahead of the game.

UnitedHealth Group’s Optum health services business is working on a turnaround that includes leaving markets and ending ...

UnitedHealth Group (NYSE: UNH) today reported full year and fourth quarter 2025 results and issued its 2026 outlook.

The Philadelphia region’s largest health system has sued several drugmakers and pharmacy benefit managers, alleging “concerted efforts” to artificially raise insulin prices that led to greater ...